Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy-Reference-Cited by-同舟云学术

Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy

Published:2011-09-23 Issue:2 Volume:53 Page:263-269
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Cox M. Christina,Ambrogi Vincenzo,Lanni Valerio,Cavalieri Elena,Pelliccia Sabrina,Scopinaro Francesco,Monarca Bruno,Marchetti Paolo,Spiriti M. Antonietta Aloe

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.614704

Reference27 articles.

1. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

2. Developments in the management of Hodgkin's lymphoma

3. Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma

4. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma

5. Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quarter-Century PET/CT Transformation of Oncology: Lymphoma;PET Clinics;2024-04

2. Значение ПЭТ, совмещенной с КТ, при диффузной В-крупноклеточной лимфоме: история вопроса, эволюция представлений и современные возможности метода (обзор литературы);Clinical Oncohematology;2024-02-20

3. Predicting primary treatment failure using interim FDG‐PET scanning in diffuse large B‐cell lymphoma;European Journal of Haematology;2021-07-22

4. End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA;Blood Advances;2021-03-02

5. Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial;Hematological Oncology;2020-10-04